Capecitabine chemoradiation for rectal cancer after curative surgery

Journal of Chemotherapy

Volumn 18, Issue 1, 2006, Pages 85-89

  Bajetta, Emilio ^a   Beretta, E ^a   Di Bartolomeo, M ^a   Mariani, L ^a   Valvo, F ^a   Ferrario, E ^a   Mancin, M ^a   Dognini, G ^a   Buzzoni, R ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Adjuvant chemotherapy; Capecitabine; Radiosensitization; Rectal cancer

Indexed keywords

ALANINE AMINOTRANSFERASE; CAPECITABINE; FLUOROPYRIMIDINE DERIVATIVE; FLUOROURACIL; FOLINIC ACID;

ABDOMINAL PAIN; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANGINA PECTORIS; ARTICLE; ASTHENIA; BOLUS INJECTION; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CLINICAL ARTICLE; CONJUNCTIVITIS; CYSTITIS; DIARRHEA; DISEASE SEVERITY; DRUG SAFETY; DRUG TOLERABILITY; EPITHELIOSIS; FEASIBILITY STUDY; FEMALE; HAND FOOT SYNDROME; HUMAN; LEUKOPENIA; LIVER DYSFUNCTION; MALE; NAUSEA; PAIN; PERIANAL PAIN; POSTOPERATIVE CARE; PROCTITIS; RADIOSENSITIZATION; RECTUM CANCER; TENESMUS; THROMBOCYTOPENIA; VOMITING;

EID: 33645100321     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2006.18.1.85     Document Type: Article

References (16)

1. Krook JE, Moertel CG, Gunderson LL, et al. Effective surgical adjuvant therapy for high risk rectal carcinoma. N Engl J Med 1991; 324: 709-715.
2. Fisher B, Wolmark N, Rockette H, et al. Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01. J Natl Cancer Inst 1988; 80: 21-29.
3. Byfield JE, Calabro-Jones P, Klisak I, et al. Pharmacologic requirements for obtaining sensitization of human tumor cells in vitro to combined 5-fluorouracil or florafur and X rays. Int J Radiat Oncol Biol Phys 1982; 8: 1923-1933.
4. Rich TA, Shepard RC, Mosley ST. Four decades of continuing innovation with fluorouracil: current and future approaches to fluorouracil chemoradiation therapy. J Clin Oncol 2004; 22: 2214-2232.
5. O'Connell MJ, Martenson JA, Wieand HS, et al. Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med 1994; 331: 502-507.
6. Miwa M, Ura M, Nishida M, et al. Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumors by enzymes concentrated in human liver and cancer tissue. Eur J Cancer 1998; 34: 1274-1281.
7. Schuller J, Cassidy J, Dumont E, et al. Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients. Cancer Chemother Pharmacol 2000; 45: 291-297.
8. 14C-labelled drug. Invest New Drugs 1999; 17: 49-56.
9. Sawada N, Ishikawa T, Sekiguchi F, et al. X-ray irradiation induces thymidine phosphorylase and enhances the efficacy of capecitabine (Xeloda) in human cancer xenografts. Clin Cancer Res 1999; 5: 2948-2953.
10. Ishitsuka H. Capecitabine: preclinical pharmacology studies. Invest New Drugs 2000; 18: 343-354.
11. Dunst J, Reese T, Sutter T, et al. Phase I trial evaluating the concurrent combination of radiotherapy and capecitabine in rectal cancer. J Clin Oncol 2002; 20: 3983-3991.
12. Souglakos J, Androulakis N, Mavroudis D, et al. Multicenter dose-finding study of concurrent capecitabine and radiotherapy as adjuvant treatment for operable rectal cancer. Int J Radiat Oncol Biol Phys 2003; 56: 1284-1287.
13. Tepper JE, O'Connell MJ, Petroni GR, et al. Adjuvant postoperative fluorouracil-modulated chemotherapy combined with pelvic radiation therapy for rectal cancer: initial results of intergroup 0114. J Clin Oncol 1997; 15: 2030-2039.
14. Sauer R, for the German Rectal Cancer Group. Adjuvant versus neoadjuvant combined modality treatment for locally advanced rectal cancer: first results of the German Rectal Cancer Study (CAO/ARO/AIO-94). Int J Radiat Oncol Biol Phys 2003; 57(Suppl. 1): S124-S125.
15. Minsky BD, Coia L, Haller DG, et al. Radiation therapy for rectosigmoid and rectal cancer: results of the 1992-1994 Patterns of Care process survey. J Clin Oncol 1998; 16: 2542-2547.
16. Gunderson LL, Sargent DJ, Tepper JE, et al. Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: a pooled analysis. J Clin Oncol 2004; 22: 1785-1796.